GSK Recalls 600,000 Ventolin Inhalers From U.S.

Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique. The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848. The inhalers, according to reports, have been distributed to []The post GSK Recalls 600,000 Ventolin Inhalers From U.S. appeared first on Independent Newspapers Limited.
Click here to read full news..